Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MAR001 in adults with hypertriglyceridemia (including remnant cholesterol); the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MAR001

Snippet

Sponsor: Marea Therapeutics | Conditions: Hypertriglyceridemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING